The government has allocated 29,250 additional vials of Amphotericin-B drug to states and Union Territories, Union Minister for Chemicals and Fertilisers Sadananda Gowda said on Wednesday. Amphotericin-B is used to treat Mucormycosis, also known as Black Fungus, which damages the nose, eyes, sinuses, and sometimes even the brain. Additional 29,250 vials of #Amphotericin- B drug, used in treatment of #Mucormycosis, have been allocated to all the States/UTs today. The allocation has been made based on the number of patients under treatment which is 11,717 across the country, Gowda tweeted. The government has allocated 7,210 vials to Gujarat, followed by 6,980 vials to Maharashtra as part of the 29,250 fresh allocation.
Gujarat reported a maximum of 2,859 mucormycosis patients under treatment till May 25 night followed by Maharashtra (2,770), Andhra Pradesh (768), Madhya Pradesh (752), Telangana (744), Uttar Pradesh (701), Central institutions (592), Rajasthan (492), Karnataka (481), Haryana (436), Tamil Nadu (236), Bihar (215).
The Centre has allocated to states and Union Territories (UTs) 29,250 additional vials of Amphotericin-B, a key drug to treat raging mucormycosis cases in India for the 11,717 patients currently being treated at different hospitals across the .
1961
New Delhi, May 26
The Centre has allocated to states and Union Territories (UTs) 29,250 additional vials of Amphotericin-B, a key drug to treat raging mucormycosis cases (black fungus) in India for the 11,717 patients currently being treated at different hospitals across the country.
Union Minister for Chemicals and Fertilizers D.V Sadananda Gowda announced that the additional 29,250 vials of Amphotericin-B were allocated to all states and the UTs and central institutions on Wednesday.
Besides this, 19,420 vials of Amphotericin-B were allocated on May 24, and 23,680 vials of the drug on May 21, Gowda informed through his tweet.
Mucormycosis is one of the rapidly spreading infections observed in patients recovering from Covid-19.